Ahomka: a culturally-adapted mhealth platform for management of hypertension in an urban and rural region of ghana

Active Project Grant Awarded Last action

Award ID
R33EB033166
Recipient
Awarding agency
Obligated
$1,255,904

Award facts

Completion date 83% complete
Originally
Place of performance
Medford, MA 02155, USA

Award details come from USAspending.gov.

Description

Abstract
Non-communicable diseases (ncds), including cancer, cardiovascular disease, diabetes, have become the greatest health threat for low and middle-income countries (lmic). In ghana, hypertension is recognized as a major public health challenge. The ubiquity of mobile phones in ghana and the popularity of mobile communications make IT possible to deliver mhealth interventions to our target population. However, there is crucial GAP in knowledge of the effectiveness of mobile health technology-based interventions for hypertension management in SSA. The proposed ahomka mhealth platform is an evidence-based intervention to assist with management of hypertension in an urban and rural region of ghana. Ahomka is adapted from the empower healthtm system, a proprietary software application developed by medtronic for direct patient-to- provider communication via a mobile application and text messaging for hypertension management. This US- ghana collaborative R21/R33 research project will focus on adaptation of the empower healthtm system into the local context in an urban and rural region of ghana by multi-level engagement with stakeholders. We have assembled a multi-national, multi-disciplinary team of researchers and medical device professionals with expertise in mobile technology development, hypertension, cardiology, population studies, and public health across multiple institutions in ghana (university of ghana, university of health and allied sciences, medtronic labs ghana) and the USA (beth israel deaconess medical center, tufts university). The proposed feasibility studies will be conducted at two large cardiovascular clinics in the greater accra region and the volta region in ghana. Phase one aims to (1) implement a user-centered, iterative design approach to adapt the mhealth platform based on feedback from stakeholders, and (2) conduct a 6-month usability and feasibility study with a cohort of patients. Phase two aims to conduct a 12-month feasibility study to assess change in blood pressure among a cohort of patients in two regions of ghana. In order to accelerate mobile health research in ghana, we propose to form the ahomka research and education network as part of the strategic capacity building plan.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $50,000
Amendment $0
Amendment $197,656
Amendment $260,346
Amendment $84,749
Amendment $84,749
Amendment $289,202
Original award $289,202
Show all 13

Subawards

Subrecipient Amount Awarded
University Of Ghana Prof. Tettey will provide guidance on the development of the feasibility study to assess the usability of the AHOMKA platform. The research team will organize… $50,000
Beth Israel Deaconess Medical Center, Inc. Dr. Kpodonu will provide clinical expertise in hypertension management and work closely with the technology partner Medtronic Labs-Ghana in incorporating… $4,077
Beth Israel Deaconess Medical Center, Inc. $33,136
University Of Ghana In Year 1 of the project, Prof. Tettey will provide guidance on the development of the feasibility study to assess the usability of the AHOMKA platform. The… -$48,600
University Of Ghana $135,000
Beth Israel Deaconess Medical Center, Inc. Dr. Kpodonu will provide clinical expertise in hypertension management and work closely with the technology partner Medtronic Labs-Ghana in incorporating… -$68,598
University Of Ghana Research $135,000
Beth Israel Deaconess Medical Center, Inc. Dr. Kpodonu will provide clinical expertise in hypertension management and work closely with the technology partner Medtronic Labs-Ghana in incorporating… $86,450

Quick answers

Who received award R33EB033166?

R33EB033166 was awarded to Trustees Of Tufts College by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on July 1, 2023.

How much is award R33EB033166 worth?

$1,255,904 has been obligated on R33EB033166.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award